Know How to Best Treat Prostate Cancer with Genetic Testing

1 in 9 men will be diagnosed with prostate cancer this year. Approximately 90% of men will be treated for their cancer through either surgery or radiation and yet approximately half of those men could have avoided treatment and the associated side effects including urinary incontinence and sexual dysfunction.

“With the new diagnosis of prostate cancer, prostate cancer has been over treated for a period of time because until now we haven’t had a very sharp tool to help separate out the men with nonaggressive types of prostate cancer that can safely be watched and those with a more aggressive type that need to be treated. We now have that with genetic testing in the Prolaris test which we can use on the prostate biopsy sample to help determine who is safe to watch and who needs their prostate cancer treated. Using this helps reduce the over treatment of prostate cancer. The numbers are that probably 50% of those men don’t need the treatment.”

Listen to Dr. Mark Edney, MD and incoming President of the American Association of Clinical Urologists as he speaks with a local Memphis TV station.